Abstract
Objective:
Evaluate spontaneous intestinal perforation (SIP)/death among extremely low birthweight (ELBW) infants before, during and after initiation of an antenatal magnesium for neuroprotection protocol (MgPro).
Study Design:
We tested associations between SIP/death and magnesium exposure, gestational age (GA) and interactions with GA and magnesium exposure in a cohort of inborn ELBW infants before, during and after MgPro.
Result:
One hundred and fifty-five ELBW infants were included, 81 before, 23 during and 51 after MgPro. ELBW infants (78.3%) were exposed to Mg during MgPro compared with 50.6% and 60.8% before and after, respectively. Incidence of SIP on protocol was 30.4% vs 12.9% off protocol (P=0.03). GA was strongly associated with SIP (P<0.01). Antenatal Mg dose was also associated with SIP/death regardless of epoch (odds ratio 9.3 (1.04–104.6)), but increased SIP/death was limited to those <25 weeks gestation.
Conclusion:
Higher Mg dose was associated with higher SIP and death risk among infants with the lowest birthweights. Validation of this observation in larger populations is warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mittendorf R . Magnesium sulfate tocolysis: time to quit. Obstet Gynecol 2007; 109 (5): 1204–1205.
Nelson KB, Grether JK . Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995; 95 (2): 263–269.
Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P . Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996; 276 (22): 1805–1810.
Boyle CA, Yeargin-Allsopp M, Schendel DE, Holmgreen P, Oakley GP . Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. Am J Epidemiol 2000; 152 (2): 120–124.
Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB . Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstetr Gynecol 2000; 183 (3): 717–725.
Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M et al. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet 1997; 350 (9090): 1517–1518.
Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186 (6): 1111–1118.
O'Shea TM, Klinepeter KL, Dillard RG . Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol 1998; 147 (4): 362–369.
Paneth N, Jetton J, Pinto-Martin J, Susser M . Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. Pediatrics 1997; 99 (5): p. art. no.–e1.
Crowther CA, Jetton J, Pinto-Martin J, Susser M et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003; 290 (20): 2669–2676.
Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Austruc D, Delaporte B et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 2008; 36 (3): 278–288.
Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (9): 895–905.
Walsh MC, Kliegman RM . Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin N Am 1986; 33 (1): 179–201.
Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114 (6): 1649–1657.
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D . Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; (1): CD004661.
Satake K, Lee JD, Shimizu H, Uzui H, Mitsuke Y, Yue H et al. Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells. Magnes Res 2004; 17 (1): 20–27.
Havranek T, Ashmeade TL, Afanador M, Carver JD . Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates. Neonatology 2011; 100 (1): 44–49.
Lu JF, Nightingale CH . Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet 2000; 38 (4): 305–314.
Shokry M, Elsedfy GO, Bassiouny MM, Anmin M, Abozid H . Effects of antenatal magnesium sulfate therapy on cerebral and systemic hemodynamics in preterm newborns. Acta Obstet Gynecol Scand 2010; 89 (6): 801–806.
Santafe MM, Garcia N, Lanuza MA, Tomàs M, Besalduch N, Tomàs J . Presynaptic muscarinic receptors, calcium channels, and protein kinase C modulate the functional disconnection of weak inputs at polyinnervated neonatal neuromuscular synapses. J Neurosci Res 2009; 87 (5): 1195–1206.
Gordon PV, Price WA, Stiles AD, Rutledge JC . Early postnatal dexamethasone diminishes transforming growth factor alpha localization within the ileal muscularis propria of newborn mice and extremely low-birth-weight infants. Pediatr Dev Pathol 2001; 4 (6): 532–537.
Gordon PV, Paxton JB, Herman AC, Carlisle EM, Fox NS . Igf-I accelerates ileal epithelial cell migration in culture and newborn mice and may be a mediator of steroid-induced maturation. Pediatr Res 2004; 55 (1): 34–41.
Gordon PV . Understanding intestinal vulnerability to perforation in the extremely low birth weight infant. Pediatr Res 2009; 65 (2): 138–144.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Rattray, B., Kraus, D., Drinker, L. et al. Antenatal magnesium sulfate and spontaneous intestinal perforation in infants less than 25 weeks gestation. J Perinatol 34, 819–822 (2014). https://doi.org/10.1038/jp.2014.106
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2014.106
This article is cited by
-
Risk factors and epidemiology of spontaneous intestinal perforation among infants born at 22–24 weeks’ gestational age
Journal of Perinatology (2024)
-
Antenatal Magnesium Sulfate and adverse gastrointestinal outcomes in Preterm infants—a systematic review and meta-analysis
Journal of Perinatology (2023)
-
Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)
Pediatric Research (2023)
-
Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32Â weeks of gestation
Scientific Reports (2020)
-
Impact of umbilical cord milking and pasteurized donor human milk on necrotizing enterocolitis: a retrospective review
BMC Pediatrics (2018)